A detailed history of Rafferty Asset Management, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 126,019 shares of IDYA stock, worth $3.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
126,019
Previous 131,096 3.87%
Holding current value
$3.2 Million
Previous $4.6 Million 13.26%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.37 - $43.05 $154,188 - $218,564
-5,077 Reduced 3.87%
126,019 $3.99 Million
Q2 2024

Aug 13, 2024

SELL
$34.37 - $43.46 $2.41 Million - $3.05 Million
-70,195 Reduced 34.87%
131,096 $4.6 Million
Q1 2024

May 13, 2024

BUY
$34.2 - $47.13 $271,377 - $373,976
7,935 Added 4.1%
201,291 $8.83 Million
Q4 2023

Feb 13, 2024

BUY
$24.59 - $35.83 $1.58 Million - $2.3 Million
64,280 Added 49.8%
193,356 $6.88 Million
Q3 2023

Nov 13, 2023

BUY
$21.07 - $29.77 $85,523 - $120,836
4,059 Added 3.25%
129,076 $3.48 Million
Q2 2023

Aug 11, 2023

SELL
$13.33 - $25.53 $34,871 - $66,786
-2,616 Reduced 2.05%
125,017 $2.94 Million
Q1 2023

May 11, 2023

SELL
$13.49 - $18.72 $359,238 - $498,513
-26,630 Reduced 17.26%
127,633 $1.75 Million
Q4 2022

Feb 13, 2023

BUY
$14.47 - $18.17 $609,823 - $765,756
42,144 Added 37.59%
154,263 $2.8 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $627,876 - $1.07 Million
67,952 Added 153.85%
112,119 $1.67 Million
Q2 2022

Aug 12, 2022

SELL
$8.28 - $13.88 $536,312 - $899,035
-64,772 Reduced 59.46%
44,167 $610,000
Q1 2022

May 13, 2022

BUY
$11.18 - $24.02 $24,976 - $53,660
2,234 Added 2.09%
108,939 $1.22 Million
Q4 2021

Feb 10, 2022

BUY
$20.95 - $26.88 $1.58 Million - $2.02 Million
75,230 Added 239.02%
106,705 $2.52 Million
Q3 2021

Nov 10, 2021

BUY
$17.26 - $27.08 $543,258 - $852,343
31,475 New
31,475 $802,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.22B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.